As of May 27, 2025, Outlook Therapeutics Inc (OTLK) reports a Graham Number of N/A.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Comparing Outlook Therapeutics Inc's Graham Number to Peers
To better understand Outlook Therapeutics Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Outlook Therapeutics Inc (OTLK) | - |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Oncology Pharma Inc (ONPH) | 77.95 |
| Amgen Inc (AMGN) | 43.25 |
Compared to its competitors, Outlook Therapeutics Inc's Graham Number is difficult to compare due to insufficient data.